VF
ARTL icon

Virtu Financial’s Artelo Biosciences ARTL Stock Holding History

Virtu Financial’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,622
Closed -$21K – 1617
2025
Q4 		$21K Buy
+5,622
New +$43.6K ﹤0.01% 1412
2022
Q3 		– Sell
-234
Closed -$20K – 1708
2022
Q2 		$20K Buy
234
+146
+166% +$14.4K ﹤0.01% 1324
2022
Q1 		$11K Sell
88
-580
-87% -$66.6K ﹤0.01% 1354
2021
Q4 		$94K Buy
668
+509
+320% +$101K 0.01% 1154
2021
Q3 		$34K Buy
159
+75
+89% +$19.1K ﹤0.01% 1321
2021
Q2 		$27K Sell
84
-486
-85% -$166K ﹤0.01% 1391
2021
Q1 		$251K Buy
+570
New +$244K 0.02% 922

Other funds holding ARTL

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Virtu Financial's ARTL Position: Q1 2026 in Review

Virtu Financial sold out of Artelo Biosciences (ARTL) in Q1 2026, closing a stake of 5,622 shares — an estimated $21K sold.

Virtu Financial first reported a position in ARTL in Q1 2021 and held it in 7 quarters. The position peaked at $251K in Q1 2021. 11 funds tracked by Wall St. Rank hold ARTL as of Q1 2026.

  • Virtu Financial reported no remaining Artelo Biosciences position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 5,622 Artelo Biosciences shares in Q1 2026, an estimated $21K.
  • Virtu Financial first reported a position in Artelo Biosciences in Q1 2021 and held it in 7 quarters.
  • Virtu Financial's Artelo Biosciences position peaked at $251K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Artelo Biosciences as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.